For new AVFs, the proactive SNDR cannulation strategy suggests it as a potentially promising protective and cost-effective approach, significantly extending PTA-free survival, reducing complications and healthcare costs, and improving the patient experience compared to conventional cannulation.
Ma et al. (2026) studied this question.